Top compounds associated with response to DRAM2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.014 0.7
mRNA LAQ824 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.02 0.7
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.012 0.7
mRNA BX-795 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA avicin D CTRPv2 pan-cancer AAC -0.02 0.7
Download CSV